GlassScriptPhysician profile
Steven C Horowitz
NPI 1912063934
$1,628.47
in general payments reported to CMS, 2019-2025
20 companies · $69.20 in 2025
The $69.20 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $778 · 2020: $423 · 2021: $98.63 · 2022: $223 · 2023: $14.31 · 2024: $22.60 · 2025: $69.20.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $106.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $395.83 | 2019-2025 | Salvation, Iconix, Inspace |
| Si-Bone, INC. | $239.22 | 2019-2021 | |
| Nevro Corp. | $152.03 | 2019-2021 | |
| Amgen INC. | $125.00 | 2020 | |
| Abbott Laboratories | $119.09 | 2019-2020 | |
| Boston Scientific Corporation | $112.92 | 2019-2022 | |
| Depuy Synthes Sales INC. | $80.56 | 2019-2025 | Motoband |
| Abbvie INC. | $73.17 | 2022 | |
| Horizon Therapeutics Plc | $45.52 | 2019 | |
| Davol INC. | $41.93 | 2022 | |
| Aesculap Implant Systems, LLC | $39.82 | 2019 | |
| Ferring Pharmaceuticals INC. | $37.67 | 2020-2022 | |
| Fidia Pharma USA INC. | $37.10 | 2021-2024 | Hyalgan, Triluron, Hymovis |
| Arteriocyte Medical Systems, INC. | $27.73 | 2019 | |
| Saluda Medical Americas, INC. | $27.19 | 2025 | Evoke |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $19.00 | 2019 | |
| Zyla Life Sciences, INC. | $14.70 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.50 | 2022 | |
| Orthofix Medical, INC. | $13.79 | 2021 | |
| Theragen, INC. | $11.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Horowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.